Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024


Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced it will host a webcast and conference call on Wednesday, May 8 at 8:00 a.m. ET to discuss its first quarter 2024 financial results and recent business highlights.

The webcast can be accessed under "Events and Presentations" on the Investors section of the Viridian website at viridiantherapeutics.com. To participate in the conference call, please dial 800-715-9871 (domestic) or 646-307-1963 (international) and reference code 7373356. A replay of the webcast will be available following the completion of the event.

About Viridian Therapeutics

Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian's expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas.

Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian's goal is to advance VRDN-001 as a potential best-in-class intravenous therapy followed by VRDN-003 as a potential first- and best-in-class subcutaneous therapy for the treatment of TED.

In addition to its TED portfolio, Viridian is advancing a novel portfolio of neonatal Fc receptor (FcRn) inhibitors, including VRDN-006 and VRDN-008, which has the potential to be developed in multiple autoimmune diseases.

Viridian is based in Waltham, Massachusetts. For more information, please visit www.viridiantherapeutics.com. Follow Viridian on LinkedIn and X.


These press releases may also interest you

at 12:45
Promising Findings on Kidney Function Preservation in IgA Nephropathy Patients at National Kidney Foundation Spring Clinical Meetings
A new study to shed light on the long-term nephroprotective potential of sparsentan compared to maximally titrated irbesartan (MT-IRB) in patients with IgA nephropathy (IgAN) is set to be presented as a late-breaking presentation at the annual 2024...

at 12:35
Poxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 12:33
The Foundation Assar Gabrielsson Prize recipients 2024 awarded
Assar Gabrielsson was one of the founders of Volvo. In accordance with his wishes, a fund was established for clinical research of cancer diseases. The fund has existed since 1962. It primarily supports research projects that are considered promising...

at 12:30
The University of Colorado Anschutz Medical Campus Selects Dr. John H. Sampson as Dean of the School of Medicine and Vice Chancellor for Health Affairs
Following a competitive national search, the University of Colorado Anschutz Medical Campus is proud to announce that John H. Sampson, MD, PhD, MHSc, MBA, has been selected as the University of Colorado School of Medicine Dean and Vice Chancellor for...

at 12:24
Restored Smiles Ranch to Showcase at CDA 2024: Dentists Invited to Connect with Founder, Dr. Jedediah Huss and Enter to Win Prizes
Restored Smiles is set to shine at the California Dental Association (CDA) Conference 2024, showcasing foundational dental courses and offering exciting opportunities for dentists to win prizes and explore the next steps in their training journey....

at 12:23
Cleaning Instructions for Medical Instruments Need an Overhaul
Infection preventionists are reaching out to policymakers for help with the regulatory process around the current convoluted medical device cleaning instructions, known as instructions for use or IFUs, with which they must comply and are calling for...

More news about Health...


News published on and distributed by: